Table 2.
Intraoperative and postoperative data (n=49)
| Characteristic | Value |
|---|---|
| Surgical approach | |
| Thoracoscopic surgery | 38 (77.6) |
| Thoracotomy | 11 (22.4) |
| Extent of resection | |
| Sublobar resection | 9 (18.4) |
| Lobectomy | 38 (75.6) |
| Bilobectomy | 2 (4.1) |
| Surgical margin | |
| R0 resection | 46 (93.9) |
| R1/2 resection | 3 (6.1) |
| Histology | |
| Pure type | 40 (81.6) |
| Mixed type | 9 (18.4) |
| Pathologic T stage | |
| pT1 | 26 (53.1) |
| pT2a | 17 (34.7) |
| pT2b | 0 |
| pT3 | 6 (12.2) |
| Harvested lymph nodes | 25.0 (16.0–37.0) |
| Pathologic N stage | |
| pN0 | 39 (79.6) |
| pN1 | 8 (16.3) |
| pN2 | 2 (4.1) |
| Pathologic stage | |
| pIA | 21 (42.9) |
| pIB | 12 (24.5) |
| pIIA | 0 |
| pIIB | 12 (24.5) |
| pIIIA | 2 (4.1) |
| pIVA | 2 (4.1) |
| Adjuvant treatment | |
| Adjuvant chemotherapy | 39 (79.6) |
| Adjuvant CCRT | 1 (2.0) |
| Prophylactic cranial irradiation | 7 (14.3) |
| 90-Day mortality | 0 |
| Follow-up duration (mo) | 41.1 (23.1–70.1) |
Values are presented as number (%) or median (interquartile range).
CCRT, concurrent chemoradiation therapy.